Patents Assigned to FONDAZIONE CENTRO SAN RAFFAELE
  • Modified cytokines for use in cancer therapy
    Publication number: 20040018171
    Abstract: Cytokine derivatives capable of homing the tumoral vessels and the antigen presenting cells and the use thereof as antitumoral agents.
    Type: Application
    Filed: April 30, 2003
    Publication date: January 29, 2004
    Applicant: FONDAZIONE CENTRO SAN RAFFAELE DEL MONTE TABOR
    Inventor: Angelo Corti
  • Modified cytokines for use in cancer therapy
    Publication number: 20030157056
    Abstract: Cytokine derivatives capable of homing the tumoral vessels and the antigen presenting cells and the use thereof as antitumoral agents.
    Type: Application
    Filed: November 5, 2002
    Publication date: August 21, 2003
    Applicant: FONDAZIONE CENTRO SAN RAFFAELE DEL MONTE TABOR
    Inventor: Angelo Corti
  • Modified cytokines for use in cancer therapy
    Publication number: 20030157055
    Abstract: Cytokine derivatives capable of homing the tumoral vessels and the antigen presenting cells and the use thereof as antitumoral agents.
    Type: Application
    Filed: August 15, 2002
    Publication date: August 21, 2003
    Applicant: FONDAZIONE CENTRO SAN RAFFAELE DEL MONTE TABOR
    Inventor: Angelo Corti
  • Rantes mutants and therapeutic applications thereof
    Patent number: 6608177
    Abstract: RANTES mutants characterized by the substitution or addition of amino acids at the N-terminal or RANTES wild-type sequence and in the N loop and/or 40′ loop regions of RNATES wild-type sequence, and their use as anti-HIV, anti-allergic or anti-inflammatory agents.
    Type: Grant
    Filed: June 9, 2000
    Date of Patent: August 19, 2003
    Assignee: Fondazione Centro San Raffaele del Monte Tabor
    Inventors: Paolo Lusso, Simona Polo
  • UPAR mimicking peptide
    Patent number: 6462170
    Abstract: Peptides comprising the SRSRY sequence (SEQ ID NO: 7) derived from the uPAR (urokinase receptor) are endowed with chemotactic activity, making them useful for preventing or activating the migration of cells in a mammal. More particularly, the peptides of the invention are useful for the treatment of cancer, autoimmune diseases, and/or hyperinflammatory diseases and for stimulating wound healing.
    Type: Grant
    Filed: October 20, 1999
    Date of Patent: October 8, 2002
    Assignees: Fondazione Centro San Raffaele del Monte Tabor, Universita Degli Studi di Milano
    Inventors: Francesco Blasi, Francesca Fazioli, Massimo Resnati, Nicolai Sidenius